Related Experiment Video
Updated: Jul 12, 2026
The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
Published on: November 19, 2008
Mast cell stabilization limits hypoxic-ischemic brain damage in the immature rat
Yuxuan Jin1, Ann-Judith Silverman, Susan J Vannucci
1Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY 10032, USA. yj2116@columbia.edu
Insights
Mast cells (MCs) contribute to infant brain damage from perinatal hypoxic-ischemic (HI) events. Stabilizing MCs with cromolyn significantly reduced HI-induced brain injury in a neonatal rat model.
Area of Science:
- Neuroscience
- Immunology
- Developmental Biology
Background:
- Perinatal hypoxic-ischemic (HI) brain damage is a leading cause of infant mortality and neurological disability.
- Mast cells (MCs) are immune cells involved in inflammatory responses and are present in the developing brain.
- The role of MCs in HI brain damage remains largely unexplored.
Purpose of the Study:
- To investigate the involvement of mast cells (MCs) in perinatal hypoxic-ischemic (HI) brain damage.
- To determine if MC activation contributes to the extent of brain injury in neonatal rats.
- To evaluate the therapeutic potential of MC stabilization in mitigating HI brain damage.
Main Methods:
- Utilized a validated model of unilateral hypoxia-ischemia (HI) in neonatal rats.
- Quantified mast cell (MC) numbers in the brain following HI using immunohistochemistry.
- Administered disodium cromoglycate (cromolyn), an MC stabilizer, before and/or after HI to assess its effects.
Main Results:
- Hypoxia-ischemia (HI) significantly increased mast cell (MC) numbers in the affected (ipsilateral) hemisphere.
- MC numbers also increased following hypoxia alone, indicating sensitivity to ischemic conditions.
- Cromolyn treatment inhibited MC migration into the central nervous system (CNS) and reduced brain damage by over 50%.
Conclusions:
- Mast cells (MCs) are key contributors to the severity of brain damage following perinatal hypoxia-ischemia (HI).
- MC activation and migration into the CNS exacerbate HI-induced neuropathology in immature animals.
- Stabilizing mast cells (MCs) represents a promising therapeutic strategy for reducing brain injury in neonatal HI.
Abstract:
Perinatal hypoxic-ischemic (HI) brain damage is a major cause of mortality and neurological morbidity in infants and children. Using an established model of unilateral hypoxia-ischemia in neonatal rats, the present study focused on mast cells (MCs), important regulators of inflammatory processes, as potential contributors to HI damage. MCs are present in the pia of the neonatal rat, entering the central nervous system (CNS) during cerebral development along penetrating blood vessels. Following hypoxia-ischemia, MC numbers increased dramatically in the ipsilateral (ischemic) hemisphere (p < 0.01). In animals exposed to hypoxia only, the numbers of MCs were elevated in both hemispheres to an extent equal to that observed in the contralateral hemisphere of HI animals (p < 0.05 vs. control). Within damaged areas (ipsilateral only), MCs were observed in regions of activated microglia and astroglia that characterize the ischemic hemisphere. Using a triple-label paradigm, MCs were observed along elongating blood vessels, some of which express the GLUT1 isoform of the glucose transporter protein, indicative of blood-brain barrier vessels. To determine whether MC activation has a role in HI brain damage, rat pups were treated with the MCs stabilizer, disodium cromoglycate (cromolyn), prior to and/or following hypoxia-ischemia. The cromolyn treatment inhibited MC migration into the CNS (p < 0.05) and limited brain damage more than 50% (p < 0.01) vs. saline controls. These data support the hypothesis that MCs are key contributors to the extent of brain damage due to hypoxia-ischemia in the immature animal.
